259 related articles for article (PubMed ID: 33519816)
21. Comparison of two different PEGylation strategies for the liposomal adjuvant CAF09: Towards induction of CTL responses upon subcutaneous vaccine administration.
Schmidt ST; Olsen CL; Franzyk H; Wørzner K; Korsholm KS; Rades T; Andersen P; Foged C; Christensen D
Eur J Pharm Biopharm; 2019 Jul; 140():29-39. PubMed ID: 31055066
[TBL] [Abstract][Full Text] [Related]
22. Enhanced antigen-specific primary CD4+ and CD8+ responses by codelivery of ovalbumin and toll-like receptor ligand monophosphoryl lipid A in poly(D,L-lactic-co-glycolic acid) nanoparticles.
Hamdy S; Elamanchili P; Alshamsan A; Molavi O; Satou T; Samuel J
J Biomed Mater Res A; 2007 Jun; 81(3):652-62. PubMed ID: 17187395
[TBL] [Abstract][Full Text] [Related]
23. Loss of DAP12 and FcRγ drives exaggerated IL-12 production and CD8(+) T cell response by CCR2(+) Mo-DCs.
Gmyrek GB; Akilesh HM; Graham DB; Fuchs A; Yang L; Miller MJ; Sandoval GJ; Sheehan KC; Schreiber RD; Diamond MS; Swat W
PLoS One; 2013; 8(10):e76145. PubMed ID: 24155889
[TBL] [Abstract][Full Text] [Related]
24. A Lipid Based Antigen Delivery System Efficiently Facilitates MHC Class-I Antigen Presentation in Dendritic Cells to Stimulate CD8(+) T Cells.
Maji M; Mazumder S; Bhattacharya S; Choudhury ST; Sabur A; Shadab M; Bhattacharya P; Ali N
Sci Rep; 2016 Jun; 6():27206. PubMed ID: 27251373
[TBL] [Abstract][Full Text] [Related]
25. Liposomes containing monophosphoryl lipid A and QS-21 serve as an effective adjuvant for soluble circumsporozoite protein malaria vaccine FMP013.
Genito CJ; Beck Z; Phares TW; Kalle F; Limbach KJ; Stefaniak ME; Patterson NB; Bergmann-Leitner ES; Waters NC; Matyas GR; Alving CR; Dutta S
Vaccine; 2017 Jul; 35(31):3865-3874. PubMed ID: 28596090
[TBL] [Abstract][Full Text] [Related]
26. Marina crystal minerals (MCM) activate human dendritic cells to induce CD4+ and CD8+ T cell responses in vitro.
Ghoneum MH; Ogura T; Gimzewski JK; Ghoneum AD; Henary MC; Agrawal S
Int J Immunopathol Pharmacol; 2018; 32():2058738418797768. PubMed ID: 30270704
[TBL] [Abstract][Full Text] [Related]
27. Presentation of proteins encapsulated in sterically stabilized liposomes by dendritic cells initiates CD8(+) T-cell responses in vivo.
Ignatius R; Mahnke K; Rivera M; Hong K; Isdell F; Steinman RM; Pope M; Stamatatos L
Blood; 2000 Nov; 96(10):3505-13. PubMed ID: 11071648
[TBL] [Abstract][Full Text] [Related]
28. Roles of Aluminum Hydroxide and Monophosphoryl Lipid A Adjuvants in Overcoming CD4+ T Cell Deficiency To Induce Isotype-Switched IgG Antibody Responses and Protection by T-Dependent Influenza Vaccine.
Ko EJ; Lee YT; Kim KH; Lee Y; Jung YJ; Kim MC; Lee YN; Kang T; Kang SM
J Immunol; 2017 Jan; 198(1):279-291. PubMed ID: 27881702
[TBL] [Abstract][Full Text] [Related]
29. Anti-CD40 Antibody Fused to CD40 Ligand Is a Superagonist Platform for Adjuvant Intrinsic DC-Targeting Vaccines.
Ceglia V; Zurawski S; Montes M; Kroll M; Bouteau A; Wang Z; Ellis J; Igyártó BZ; Lévy Y; Zurawski G
Front Immunol; 2021; 12():786144. PubMed ID: 35095862
[TBL] [Abstract][Full Text] [Related]
30. ISCOMATRIX adjuvant combines immune activation with antigen delivery to dendritic cells in vivo leading to effective cross-priming of CD8+ T cells.
Duewell P; Kisser U; Heckelsmiller K; Hoves S; Stoitzner P; Koernig S; Morelli AB; Clausen BE; Dauer M; Eigler A; Anz D; Bourquin C; Maraskovsky E; Endres S; Schnurr M
J Immunol; 2011 Jul; 187(1):55-63. PubMed ID: 21613613
[TBL] [Abstract][Full Text] [Related]
31. Regulatory Dendritic Cells Induced by Bendamustine Are Associated With Enhanced Flt3 Expression and Alloreactive T-Cell Death.
Molina MS; Hoffman EA; Stokes J; Kummet N; Smith KA; Baker F; Zúñiga TM; Simpson RJ; Katsanis E
Front Immunol; 2021; 12():699128. PubMed ID: 34249005
[TBL] [Abstract][Full Text] [Related]
32. Vaccine Adjuvant Systems containing monophosphoryl lipid A and QS-21 induce strong humoral and cellular immune responses against hepatitis B surface antigen which persist for at least 4 years after vaccination.
Leroux-Roels G; Van Belle P; Vandepapeliere P; Horsmans Y; Janssens M; Carletti I; Garçon N; Wettendorff M; Van Mechelen M
Vaccine; 2015 Feb; 33(8):1084-91. PubMed ID: 25444781
[TBL] [Abstract][Full Text] [Related]
33. Cellular and molecular synergy in AS01-adjuvanted vaccines results in an early IFNγ response promoting vaccine immunogenicity.
Coccia M; Collignon C; Hervé C; Chalon A; Welsby I; Detienne S; van Helden MJ; Dutta S; Genito CJ; Waters NC; Deun KV; Smilde AK; Berg RAVD; Franco D; Bourguignon P; Morel S; Garçon N; Lambrecht BN; Goriely S; Most RV; Didierlaurent AM
NPJ Vaccines; 2017; 2():25. PubMed ID: 29263880
[TBL] [Abstract][Full Text] [Related]
34. Migratory CD11b
Krishnaswamy JK; Gowthaman U; Zhang B; Mattsson J; Szeponik L; Liu D; Wu R; White T; Calabro S; Xu L; Collet MA; Yurieva M; Alsén S; Fogelstrand P; Walter A; Heath WR; Mueller SN; Yrlid U; Williams A; Eisenbarth SC
Sci Immunol; 2017 Dec; 2(18):. PubMed ID: 29196450
[TBL] [Abstract][Full Text] [Related]
35. Recent clinical experience with vaccines using MPL- and QS-21-containing adjuvant systems.
Garçon N; Van Mechelen M
Expert Rev Vaccines; 2011 Apr; 10(4):471-86. PubMed ID: 21506645
[TBL] [Abstract][Full Text] [Related]
36. Selective expansion of merocytic dendritic cells and CD8DCs confers anti-tumour effect of Fms-like tyrosine kinase 3-ligand treatment in vivo.
Hennies CM; Reboulet RA; Garcia Z; Nierkens S; Wolkers MC; Janssen EM
Clin Exp Immunol; 2011 Mar; 163(3):381-91. PubMed ID: 21235535
[TBL] [Abstract][Full Text] [Related]
37. A new synthetic TLR4 agonist, GLA, allows dendritic cells targeted with antigen to elicit Th1 T-cell immunity in vivo.
Pantel A; Cheong C; Dandamudi D; Shrestha E; Mehandru S; Brane L; Ruane D; Teixeira A; Bozzacco L; Steinman RM; Longhi MP
Eur J Immunol; 2012 Jan; 42(1):101-9. PubMed ID: 22002164
[TBL] [Abstract][Full Text] [Related]
38. The Lymphatic Immune Response Induced by the Adjuvant AS01: A Comparison of Intramuscular and Subcutaneous Immunization Routes.
Neeland MR; Shi W; Collignon C; Taubenheim N; Meeusen EN; Didierlaurent AM; de Veer MJ
J Immunol; 2016 Oct; 197(7):2704-14. PubMed ID: 27549170
[TBL] [Abstract][Full Text] [Related]
39. Adjuvant-Associated Peripheral Blood mRNA Profiles and Kinetics Induced by the Adjuvanted Recombinant Protein Candidate Tuberculosis Vaccine M72/AS01 in Bacillus Calmette-Guérin-Vaccinated Adults.
van den Berg RA; De Mot L; Leroux-Roels G; Bechtold V; Clement F; Coccia M; Jongert E; Evans TG; Gillard P; van der Most RG
Front Immunol; 2018; 9():564. PubMed ID: 29632533
[TBL] [Abstract][Full Text] [Related]
40. Hepatitis C virus-like particles combined with novel adjuvant systems enhance virus-specific immune responses.
Qiao M; Murata K; Davis AR; Jeong SH; Liang TJ
Hepatology; 2003 Jan; 37(1):52-9. PubMed ID: 12500188
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
